Revive Life Science Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.49 M
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.50 M
- Revenue Growth -60.90%
- Profit Growth -154.57%
- Ebitda -115.43%
- Net Worth 24.30%
- Total Assets 13.08%
About Revive Life Science
Revive Life Science Private Limited (RLSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 03 July 2019 (Five years and seven months 2 days old ). Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.49 M.
The company currently has active open charges totaling ₹7.50 M.
Rakesh Jajoo, Prateek Jain, Mohit Agrawal, and One other member serve as directors at the Company.
Company Details
-
Location
Indore, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85200MP2019PTC049031
-
Company No.
049031
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Jul 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Revive Life Science?
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ketan Jajoo | Director | 03-Jul-2019 | Current |
Rakesh Jajoo | Director | 03-Jul-2019 | Current |
Prateek Jain | Director | 03-Jul-2019 | Current |
Mohit Agrawal | Director | 03-Jul-2019 | Current |
Financial Performance of Revive Life Science.
Revive Life Science Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 60.9% decrease. The company also saw a substantial fall in profitability, with a 154.57% decrease in profit. The company's net worth Soared by an impressive increase of 24.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Revive Life Science?
In 2023, Revive Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹7.50 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.75 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
25 Jun 2020 | Axis Bank Limited | ₹7.50 M | Open |
How Many Employees Work at Revive Life Science?
Unlock and access historical data on people associated with Revive Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Revive Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Revive Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.